PM Modi may launch health coverage for senior citizens under Ayushman Bharat next week

Prime Minister Narendra Modi may roll out a significant expansion of the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) on October 29, providing health coverage to all citizens aged 70 years and above, regardless of their income status, a PTI report quoted an official source as saying. This initiative aims to benefit approximately six crore senior citizens across 4.5 crore households.

The expanded scheme will offer free treatment up to Rs 5 lakh at any of the 29,648 hospitals empanelled under AB-PMJAY, including 12,696 private hospitals. To facilitate this, eligible individuals must register on the PMJAY portal or the Ayushman app. Those already holding an Ayushman card will need to reapply and complete their eKYC to obtain a new card.

Senior citizens aged 70 and above who belong to families already covered under AB PM-JAY will receive an additional top-up cover of Rs 5 lakh per year. Others in the same age group will receive coverage up to Rs 5 lakh per year on a family basis.

Also ReadFixed deposits offering up to 9% during festive season – Compare best FD rates

Additionally, the U-WIN portal, developed to maintain a digital registry of routine immunisations, will also be officially launched on the same day. This platform, a replication of the COVID-19 vaccine management system Co-WIN, is designed to keep a permanent digital record of vaccinations for pregnant women and children from birth to age 17 under the Universal Immunization Programme.

“The U-WIN platform will help in creating a comprehensive immunisation registry, ensuring that all vaccinations are documented and easily accessible,” the source further said.

The AB PM-JAY scheme is currently operational in 33 states and Union territories, excluding Delhi, Odisha, and West Bengal. However, citizens aged 70 or above as per their Aadhar card will be eligible to apply for the scheme.

 » Read More

Related Articles

8th Pay Commission: Central govt to merge pay scales for Level 1-6 employees? Here’s what the new proposal says

8th Pay Commission: The National Council of Joint Consultative Machinery (JCM) Staff Side has submitted its recommendations for the Terms of Reference (ToR) for the 8th Central Pay Commission (CPC), advocating significant changes in pay structure, allowances and benefits for government employees. Among the key points of ToR is the proposal for merger of certain

Bharti Airtel Q3 Results: Profit surges 505.24% to Rs 14,781.20 crore, ARPU at Rs 245

Bharti Airtel on Thursday posted a profit of Rs 14,781.20 crore during the third quarter of FY25, reporting a growth of 505.24 per cent in comparison to Rs 2442.20 crore during the corresponding quarter of FY24. The telecom major recorded Q3 revenue from operations at Rs 45,129.30 crore, up 19.08 per cent as against Rs

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

8th Pay Commission: Central govt to merge pay scales for Level 1-6 employees? Here’s what the new proposal says

8th Pay Commission: The National Council of Joint Consultative Machinery (JCM) Staff Side has submitted its recommendations for the Terms of Reference (ToR) for the 8th Central Pay Commission (CPC), advocating significant changes in pay structure, allowances and benefits for government employees. Among the key points of ToR is the proposal for merger of certain

Bharti Airtel Q3 Results: Profit surges 505.24% to Rs 14,781.20 crore, ARPU at Rs 245

Bharti Airtel on Thursday posted a profit of Rs 14,781.20 crore during the third quarter of FY25, reporting a growth of 505.24 per cent in comparison to Rs 2442.20 crore during the corresponding quarter of FY24. The telecom major recorded Q3 revenue from operations at Rs 45,129.30 crore, up 19.08 per cent as against Rs

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

Two banking stocks to watch ahead of the RBI Policy

By Kiran Jani Bank Nifty reached its all-time high of 54,467 in September 2024. Following this peak, the index experienced a correction, dipping to 47,844 in January 2025—a decline of 7.29%. Despite this pullback, Kotak Bank and ICICI Bank showed relative resilience, delivering returns of 1.61% and -4.20%, respectively, during the same period. Source: Investing.com

New Tax Regime: These deductions, exemptions still available for you

The Indian government introduced a new tax regime in 2020, offering lower tax rates while removing several exemptions and deductions available under the old system. Initially optional, this regime became the default in 2023, requiring taxpayers to opt out if they wished to continue under the old structure. Despite the removal of many benefits, certain